Related Experiment Video
Updated: Jul 17, 2026
Innovative Strategies for Organ Preservation in Heart Transplantation: Uniform Cooling Preservation and Ex-situ Normothermic Perfusion
Published on: November 28, 2025
Renal protective strategies in heart transplant patients
1Multiorgan Transplant Program, Department of Medicine, Royal Victoria Hospital, McGill University Health Centre, Montréal, Québec, Canada. marcelo.cantarovich@muhc.mcgill.ca
Purpose Of Review:
Chronic renal failure associated with long-term calcineurin inhibitor immunosuppression is a substantial clinical problem in the heart transplant population, compounded by difficulties in identifying patients likely to develop renal dysfunction. Several approaches, however, have been developed or are being investigated to preserve renal function in heart transplant patients.
Recent Findings:
Approaches to identify patients with an increased risk of developing renal dysfunction are being refined, and improved calcineurin inhibitor monitoring strategies are being investigated. Novel immunosuppressive regimens including mycophenolate mofetil and/or rapamycin that lack nephrotoxicity promise new therapeutic strategies with the efficacy of calcineurin inhibitor-based combinations. Temporary ('holiday') or permanent ('retirement') calcineurin inhibitor replacement with interleukin-2 receptor monoclonal antibodies has the potential to halt progressive renal dysfunction. Finally, emerging data on the renal protection afforded by angiotensin converting enzyme inhibitors and angiotensin II receptor blockers, either singly or in combination, provide another avenue of investigation.
Summary:
Several strategies have demonstrated their potential to preserve or improve renal function in heart transplant patients in small studies. Large randomized controlled trials are necessary to determine the optimal strategies to prevent rejection while preserving renal function in the long-term management of heart transplant patients.
Insights
Strategies are emerging to protect kidney function in heart transplant recipients on calcineurin inhibitors. Research is refining risk identification and exploring novel immunosuppressants and renal protective agents to prevent chronic renal failure.
Area of Science:
- Nephrology
- Cardiology
- Immunology
Background:
- Chronic renal failure is a significant complication in heart transplant recipients due to long-term calcineurin inhibitor use.
- Identifying patients at high risk for renal dysfunction remains challenging.
Purpose of the Study:
- To review current and emerging strategies for preserving renal function in heart transplant patients.
- To highlight novel approaches in immunosuppression and renal protection.
Main Methods:
- Review of current literature on calcineurin inhibitor nephrotoxicity and management strategies.
- Investigation of novel immunosuppressive agents and renal protective therapies.
Main Results:
- Refined risk identification and improved monitoring of calcineurin inhibitors are under investigation.
- Nephrotoxic-free immunosuppressive regimens (e.g., mycophenolate mofetil, rapamycin) show promise.
- Calcineurin inhibitor withdrawal or replacement with interleukin-2 receptor antibodies may halt renal dysfunction.
- Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers demonstrate potential renal protective effects.
Conclusions:
- Several strategies show potential for preserving or improving renal function in heart transplant patients in preliminary studies.
- Large randomized controlled trials are needed to establish optimal long-term management strategies for preventing rejection while preserving renal function.
Related Concept Videos
01:16Kidney Transplant III: Nursing Management
01:26Kidney Transplant II: Surgical Procedure
01:28Kidney Transplant I: Introduction
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System